Drawing for Serial No. 50020433

USPTO serial 50020433

Serial No. 50020433

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
AYALA, LOURDES
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 50020433?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas A. Rettew

Douglas A. Rettew Finnegan, Henderson, Farabow, Garrett & Dunner, LLP901 New York Avenue, NWWashington, DC 20001United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of immune system diseases and disorders; Therapeutic antibodies for the treatment of immune system diseases and disorders for human use; Therapeutic antibodies for the treatment of autoimmune diseases and disorders for human useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 21, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 19, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 19, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 19, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2026DOCKASSIGNED TO EXAMINER—
Sep 6, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 29, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 29, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance